tiprankstipranks

Matthew Strobeck Insider Profile

11 Followers
Matthew Strobeck, Director at Yield10 Bioscience, holds 325.24K shares in Accelerate Diagnostics (Ticker: AXDX), holds 5.01M shares in Biodesix (Ticker: BDSX), holds 65.20K shares in QuidelOrtho (Ticker: QDEL).
tipranks
Matthew Strobeck

Matthew Strobeck
Yield10 Bioscience (YTEN)
Director

Ranked #49,987 out of 98,624 Corporate Insiders

Profitable Transactions

57%
8 out of 14 Profitable Transactions

Average Return

-0.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
64.18%
27.31%
5.55%
2.96%
A breakdown of Matthew Strobeck's holdings

Insider Roles

Biodesix
(BDSX)
Director
QuidelOrtho
(QDEL)
Director
Yield10 Bioscience
(YTEN)
Director
Accelerate Diagnostics
(AXDX)
Director
Roles that Matthew Strobeck holds in companies

Most Profitable Insider Trade

Stock:
Accelerate Diagnostics
(AXDX)
Rating:Informative Buy
Date:Mar 20, 2020 - Mar 20, 2021
Return:+101.00%
The most profitable trade made by Matthew Strobeck

Matthew Strobeck's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Yield10 Bioscience
Jan 28, 2016
Director
Uninformative Sell
$536.96K
Accelerate Diagnostics
Jan 25, 2024
Director
Uninformative Buy
$286.53K
QuidelOrtho
Jun 08, 2023
Director
Uninformative Buy
$2.64M
Biodesix
Aug 07, 2023
Director
Uninformative Buy
500.00K
$6.21M
SNTS
Santarus
Apr 10, 2012
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Matthew Strobeck's performance on stock

Matthew Strobeck insider profile FAQ

What is the percentage of profitable transactions made by Matthew Strobeck?
The percentage of profitable transactions made by Matthew Strobeck is 57%.
    What is the average return per transaction made by Matthew Strobeck?
    The average return per transaction made by Matthew Strobeck is -0.10%.
      What stocks does Matthew Strobeck hold?
      Matthew Strobeck holds: YTEN, AXDX, QDEL, BDSX, SNTS stocks.
        What was Matthew Strobeck’s latest transaction?
        Matthew Strobeck latest transaction was an Uninformative Buy of ―.
          What was Matthew Strobeck's most profitable transaction?
          Matthew Strobeck’s most profitable transaction was an Informative Buy of AXDX stock on March 20, 2020. The return on the trade was 101.00%.
            What is Matthew Strobeck's role in Yield10 Bioscience?
            Matthew Strobeck's role in Yield10 Bioscience is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.